Table 2.
Acronyms and full names of trials mentioned in this article
| Short name | Full name |
|---|---|
| AF-CHF | Atrial Fibrillation and Congestive Heart Failure |
| AFFIRM | The Atrial Fibrillation Follow-up Investigation of Rhythm Management |
| BEST | Beta-Blocker Evaluation in Survival Trial |
| BHAT | Beta Blocker Heart Attack Trial |
| BIP | Bezafibrate Intervention Study |
| CAPRICORN | Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction |
| CHARISMA | Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance |
| CIBIS-II | Cardiac Insufficiency Bisoprolol Study |
| COMET | Carvedilol Or Metoprolol European Trial |
| COMMIT | Clopidogrel and Metoprolol in Myocardial Infarction Trial |
| COPERNICUS | Carvedilol Prospective Randomized Cumulative Survival |
| ISIS-1 | First International Study of Infarct Survival |
| J-DHF | Japanese Diastolic Heart Failure Study |
| MERIT-HF | Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure |
| MIAMI | Metoprolol in acute myocardial infarction |
| MOCHA | Multicenter Oral Carvedilol Heart Failure Assessment |
| MUSTT | Multicenter Unsustained Tachycardia Trial |
| PRECISE | Percutaneous Robotically Enhanced Coronary Intervention |
| SENIORS | Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure |
| UKPDS | UK Prospective Diabetes Study |
| β-PRESERVE | Rationale and design of the β-blocker in heart failure with normal left ventricular ejection fraction |